.Scopolamine Patch Suppliers & Bulk Manufacturers
Available Forms: Patches
Available Strengths: 1.5 mg patch
Reference Brands: Transderm-Scop
Category:
Transdermal Patches
Scopolamine patches deliver scopolamine transdermally, blocking muscarinic receptors to prevent nausea, vertigo, and motion sickness. Benefits include sustained symptom relief, reduced medication dosing frequency, minimal gastrointestinal side effects, and improved patient compliance, supporting effective prevention of motion sickness and postoperative nausea in healthcare and travel settings.
.Scopolamine Patch is available in Patches
and strengths such as 1.5 mg patch.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, .Scopolamine Patch is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
.Scopolamine Patch can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Scopolamine patches are regulated in the EU and US, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in accordance with GMP and MDR standards. In the US, FDA approval involves validation, safety testing, and compliance with safety and efficacy standards. In the EU, CE marking certifies conformity with MDR regulations. These devices undergo validation, stability testing, and audits, with comprehensive documentation including safety profiles, clinical data, and manufacturing practices. For licensing procedures, approved dossiers, and latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe, effective transdermal scopolamine therapies, supporting nausea prevention in motion sickness, postoperative care, and treatment across healthcare and travel sectors worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing